hydroxychloroquine has been researched along with Febrile Neutropenia in 2 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Febrile Neutropenia: Fever accompanied by a significant reduction in the number of NEUTROPHILS.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
de la Cruz-Benito, B | 1 |
Lázaro-Del Campo, P | 1 |
Ramírez-López, A | 1 |
de Soto-Álvarez, T | 1 |
Sánchez-Vadillo, I | 1 |
García-Pérez, E | 1 |
Dos Santos-Ortas, A | 1 |
Humala-Barbier, K | 1 |
López-de la Guía, A | 1 |
Casado-Abad, G | 1 |
Jiménez-Yuste, V | 1 |
Canales-Albendea, M | 1 |
Al-Makki, A | 1 |
Taber, T | 1 |
2 other studies available for hydroxychloroquine and Febrile Neutropenia
Article | Year |
---|---|
Managing the front-line treatment for diffuse large B cell lymphoma and high-grade B cell lymphoma during the COVID-19 outbreak.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocol | 2020 |
Neutropenic fever in COVID-19 in kidney transplant patient.
Topics: Adult; Azithromycin; Cefepime; COVID-19; COVID-19 Drug Treatment; Febrile Neutropenia; Female; Human | 2021 |